There are hundreds of types of silver products on the market today. Most are ionic or colloidal preparations; few have been EPA or FDA approved. Most work by chemical action, meaning that they must have direct contact with microbes to have any positive effect. American Biotech Labs (ABL) has engineered a unique SilverSol Technology™. This new technology works by catalytic action, not by chemical action. Because of the action of this new SilverSol Technology™, ABL can achieve results that other silver products cannot match, while remaining completely family safe and non-toxic at the levels at which it is being used. The potential applications of this technology are vast and far- reaching into many markets worldwide. ABL’s product lines currently include dietary supplements, government approved hospital and home disinfectants and a new wound care product for animals. A number of new products are also under development.
American Biotech Labs was founded in 1998 under the name American Silver LLC. Since that time, the company has changed its name to American Biotech Labs to clearly establish its identity as a bio-medical technology company. Although the concept of using silver is not a new idea, the founders spent years before ABL was incorporated, refining the process to create a far more effective agent that promotes health and well being. The end result was the creation of ABL’s unique SilverSol Technology™. American Biotech Labs is in the forefront of silver research, having completed over 50 major studies (seven independent studies) on their products and the technology behind them. American Biotech Labs has also led the way in product design and information.
